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Summary
 
To study the role of CD8
 
b
 
 in T cell function, we derived a CD8
 
a
 
/
 
b
 
2
 
 (CD8
 
2
 
/
 
2
 
) T cell hybri-
doma of the H-2K
 
d
 
–restricted N9 cytotoxic T lymphocyte clone specific for a photoreactive
derivative of the 
 
Plasmodium berghei
 
 circumsporozoite peptide PbCS 252-260. This hybridoma
was transfected either with CD8
 
a
 
 alone or together with CD8
 
b
 
. All three hybridomas released
interleukin 2 upon incubation with L cells expressing K
 
d
 
–peptide derivative complexes, though
CD8
 
a
 
/
 
b
 
 cells did so more efficiently than CD8
 
a
 
/
 
a
 
 and especially CD8
 
2
 
/
 
2
 
 cells. More strik-
ingly, only CD8
 
a
 
/
 
b
 
 cells were able to recognize a weak agonist peptide derivative variant.
This recognition was abolished by Fab
 
9
 
 fragments of the anti-K
 
d
 
 
 
a
 
3 monoclonal antibody SF1-
1.1.1 or substitution of K
 
d
 
 D-227 with K, both conditions known to impair CD8 coreceptor
function. T cell receptor (TCR) photoaffinity labeling indicated that TCR–ligand binding on
CD8
 
a
 
/
 
b
 
 cells was 
 
z
 
5- and 20-fold more avid than on CD8
 
a
 
/a and CD8
 
2
 
/
 
2
 
 cells, respec-
tively. SF1-1.1.1 Fab
 
9
 
 or K
 
d
 
 mutation D227K reduced the TCR photoaffinity labeling on
CD8
 
a
 
/
 
b
 
 cells to approximately the same low levels observed on CD8
 
2
 
/
 
2
 
 cells. These results
indicate that CD8
 
a
 
/
 
b
 
 is a more efficient coreceptor than CD8
 
a
 
/
 
a
 
, because it more avidly
strengthens TCR–ligand binding.
 
M
 
HC class I–restricted TCR
 
a
 
/
 
b
 
1
 
 T cells express het-
erodimeric CD8 consisting of a disulfide linked 
 
a
 
 and
 
b
 
 chain, whereas other cell types, such as NK cells or ex-
trathymic intraepithelial T cells, express homodimeric CD8
 
a
 
(1, 2). Whereas CD8
 
a
 
 can be surface expressed as CD8
 
a
 
/
 
a
 
homodimers, CD8
 
b
 
 is expressed only as CD8
 
a
 
/
 
b
 
 het-
erodimers (3). X-ray crystallography showed that CD8
 
a
 
 is
folded in an Ig-like manner (2, 4). For CD8
 
a
 
/
 
a
 
, a major
CD8 binding site on MHC class I molecules is the acidic
loop 222-229, located in the center of the 
 
a
 
3 domain (5, 6).
Moreover, the cytoplasmic tail of CD8
 
a
 
 has been shown
to associate with the T cell–specific tyrosine kinase p56
 
lck
 
(7, 8) and becomes phosphorylated on serine residues upon
cell activation (8, 9).
Less is known about CD8
 
b
 
. It has only 
 
z
 
30% sequence
homology with CD8
 
a
 
, and its hinge region is 13 amino
acids shorter than the one of CD8
 
a
 
 (1, 2). CD8
 
b
 
 broadens
the range of antigen recognition, e.g., CD8
 
a
 
/
 
b
 
 expressing
T cell hybridomas were able to recognize ligand variants,
but CD8
 
a
 
/
 
a
 
 expressing ones did not (10, 11). CD8
 
b
 
 also
plays a decisive role in thymic differentiation and matura-
tion, since CD8
 
b
 
 “knock out” mice have dramatically re-
duced numbers of mature CD8
 
1
 
 cells (12, 13). Transgenic
mice expressing “tailless” CD8
 
b
 
 also exhibited a reduced
number of mature CD8
 
1
 
 cells, indicating that the cytoplas-
matic portion of CD8
 
b
 
 has a functional significance (14).
The recent finding that CD8
 
b
 
 considerably increases
CD8–p56
 
lck
 
 association suggests that the tail of CD8
 
b
 
 di-
rectly or indirectly interacts with this enzyme (15).
We have previously developed a system that allows as-
sessment of TCR–ligand interactions by TCR photoaffin-
ity labeling (16, 17). To this end, the 
 
Plasmodium berghei
 
cirumsporozoite peptide PbCS 262-260 (SYIPSAEKI) was
modified by replacing PbCS S-252 with photoreactive
iodo-4-azidosalicylic acid (
 
IASA
 
) and conjugating K-259
with 4-azidobenzoic acid (
 
ABA
 
). From mice immunized
with this derivative, K
 
d
 
-restricted CTL clones were derived
that recognized this conjugate as well as the one lacking the
 
IASA
 
 group, but not the derivative lacking the 
 
ABA
 
 group
(17, 18). Selective photoactivation of 
 
IASA
 
 permitted cross-
linking of the peptide derivative to K
 
d
 
 molecules (16). In-
cubation of soluble, monomeric K
 
d
 
–peptide derivative com-
plexes with cloned CTL and photoactivation of the 
 
ABA
 
group resulted in TCR photoaffinity labeling, which was
proportional to TCR–ligand binding (16–18). This label-
ing was not dependent on integrins but dependent on CD8
participation in TCR–ligand binding.
We have previously prepared a T cell hybridoma by fus-
ing cloned T1 CTL with a TCR
 
2
 
 variant of the BW thy-
moma (19). This hybridoma expressed T1 TCR but no
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CD8, because of a fusion mediated silencing of the CD8
 
a
 
promoter and the inability of CD8
 
b
 
 to be surface expressed
in the absence of CD8
 
a
 
 (3, 20). As assessed by TCR pho-
toaffinity labeling, TCR–ligand binding on this hybridoma
was 
 
.
 
95% weaker than on T1 CTL (19). CD8
 
a
 
 transfec-
tion of the hybridoma resulted in high level expression of
CD8
 
a
 
/
 
a
 
 and weak CD8
 
a
 
/
 
b
 
 expression (CD8
 
b
 
 being
contributed by the endogenous gene). This transfection only
partially restored TCR–ligand binding, suggesting that
CD8
 
a/b (19) may strengthen TCR–ligand binding more
efficienty than CD8a/a.
In this study we tested N9 CTL-derived hybridomas that
expressed either no CD8 (CD82/2), only CD8a (CD8a/a),
or CD8a/b for antigen recognition (IL-2 release) and TCR–
ligand binding (TCR photoaffinity labeling). The results
indicate that CD8a/b cells more efficiently recognized an-
tigen, especially a weak antagonist variant, because CD8a/b
avidly strengthened TCR–ligand binding.
Materials and Methods
Peptide Derivatives and Photoaffinity Labeling Procedures. All syn-
thetic and analytic procedures were performed essentially as
described (16–18, 21). In brief, IASA-YIPSAEK(ABA)I and IASA-
YIPSAEK(BA)I were obtained by chloramine T–mediated iodi-
nation of ASA-Y(PO3H2)IPSAEK(ABA)I and ASA-Y(PO3H2)
IPSAEK(BA)I, respectively. Before deprotection and cleavage
from the resin, the peptides were NH2-terminally acylated with
4-azidosalicyloy-N-hyrdroxysuccinimidyl ester. After iodination
with 125I (z2,000 Ci/mMol) or nonradioactive iodine, the pep-
tides were dephosphorylated with alkaline phosphatase and puri-
fied by reverse phase HPLC on a C-18 column. Kd and TCR
photoaffinity labeling experiments were performed as described
(16, 17, 19). In brief, purified soluble Kd was incubated with
freshly radiolabeled peptide derivatives at ambient temperature
for 2 h, followed by UV irradiation at >350 nm and FPLC gel
filtration. For TCR photoaffinity labeling, 8 3 106 cells/ml were
resuspended in DMEM supplemented with 2% FCS and 20 mM
Hepes and incubated in 1 ml aliquots with 1.2 3 107 cpm of Kd–
peptide derivative complex for 1 h at 268C. After UV irradiation
at 312 6 40 nm, the cells were washed and lysed on ice in PBS
supplemented with NP-40, Hepes, and protease inhibitors. Im-
munoprecipitation was performed with anti-TCR mAb H57-
297, and the immunoprecipitates were analyzed by SDS-PAGE
(10% linear, reducing conditions). The dried gels were evaluated
by autoradiography and densitometry. TCR photoaffinity label-
ing experiments were performed in triplicate and repeated at least
twice.
Cell Lines. The T cell hybridoma N9.1 (CD82/2) was ob-
tained by fusing cloned N9 CTL (18) with the BW5147 TCRab2
(BW2) thymoma as described (19). N9.1 cells were transfected
with CD8a cDNA inserted in the pH pHbAPr-1-neo expression
vector (8) and selected in the presence of G418 (2.5 mg/ml). Var-
ious stable CD8a transfectants were tested by flow cytometry for
expression of CD8b, and one clone was found that was CD8b2.
This clone was transfected with a CD8b BamHI genomic fragment
DNA inserted in the pSV2-his expression vector (pCA257.10). A
representative clone (WB1.2) was selected in the presence of his-
tidinol (3 mM). All transfections were performed using protoplast
fusion (22). Murine fibroblast L cells were transfected with Kd or
KdD227K cDNA as described (23).
mAbs and Flow Cytometry. The following mAbs were used:
H57-259 (anti-TCR Cb), 53-6-72 (anti-CD8a), H35-17 (anti-
CD8b), SF1-1.1.1. (anti-Kda3), 20-8-4S (anti-Kda1), and anti-
CD3 (145.2C11). For most experiments, single staining was per-
formed with FITC- or PE-conjugated anti-CD8b and anti-Kd,
PE-conjugated anti-CD8a, and anti-TCR (mAb). Samples were
Figure 1. CD8a/b cells more efficiently recognize IASA-YIPSAEK
(ABA)I and IASA-YIPSAEK(BA)I than CD8a/a or CD82/2cells. The
IL-2 released by CD82/2 (A), CD8a/a (B), and CD8a/b (C) cells was
measured as [3H]thymidine uptake by CTLL indicator cells after incuba-
tion with L-Kd cells sensitized with IASA-YIPSAEK(ABA)I (s) or
IASA-YIPSAEK(BA)I (d). In insets, the IL-2 responses are shown as ob-
served after incubation with anti-CD3 mAb or PMA and ionomycin.
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analyzed on a FACScanÒ  (Becton Dickinson & Co., Mountain
View, CA) equipped with LYSIS II software.
IL-2 Release Assay. L-Kd or L-Kd D227K cells (5 3 106 cells/
ml) were incubated in DMEM supplemented with 0.7% FCS and
10 mM Hepes in 10 ml polypropylene tubes (Falcon Plastics, Ox-
nard, CA) with graded concentrations (1027–10214 M, in 10-fold
dilutions) of peptide derivative at 268C for 2 h. After UV irradia-
tion at >350 nm (16), cells were washed three times, resuspended
in DMEM supplemented with 5% FCS and 10 mM Hepes at 106
cells/ml, and plated in 100-ml aliquots into flat bottom 96-well
microtiter plates (Falcon Plastics). The T cell hydridomas, resus-
pended in the same medium and at the same cell density, were
added in 100-ml aliquots. Alternatively, hydridomas were incu-
bated either with anti-CD3 mAb (145.2C11, absorbed on plates)
or PMA (2.5 ng/ml) and ionomycin (0.5 mg/ml). After 24 h of
incubation at 378C, supernatants (100 ml) were transferred into
fresh microtiter plates and incubated for 36–48 h with CTLL in-
dicator cells (4 3 103 cells/100 ml/well). 1 mCi of [3H]thymidine
(Amersham Corp., Arlington Heights, IL), was added per well,
and after incubation for an additional 12 h, the cells were har-
vested and the incorporated [3H]thymidine was measured by b
counting (Inotech Harvester and Trace 96 b counter). Each ex-
periment was performed in triplicate and was repeated at least
twice.
Results and Discussion
To assess the antigen recognition of the hybridomas un-
der study, they were incubated with L cells expressing co-
valent Kd-IASA-YIPSAEK(ABA)I complexes and the re-
leased IL-2 was measured. The L-Kd cells were sensitized
by incubation with the indicated concentrations of IASA-
YIPSAEK(ABA)I and IASA-YIPSAEK(BA)I, respectively,
followed by UV irradiation at >350 nm, which produced
covalent cell-associated Kd–peptide derivative complexes.
As shown for a representative experiment in Fig. 1, all
three hybridomas produced IL-2 upon incubation with L
cells expressing Kd-IASA-YIPSAEK(ABA)I, but CD8a/b
cells more efficiently, especially at low degrees of sensitiza-
tion. Because all three hybridomas expressed comparable
levels of TCR and LFA1 (Table 1) and responded similarly
upon stimulation with anti-CD3 mAb or PMA and iono-
mycine (Fig. 1, insets), these results indicate that CD8a/b,
but less CD8a/a, increased the efficiency of antigen recog-
nition.
More strikingly, the peptide derivative variant IASA-
YIPSAEK(BA)I, which lacks the azido function of the
ABA group, was efficiently recognized only by CD8a/b
cells (Fig. 1). Half-maximal IL-2 release was observed at
.10-fold higher degree of sensitization than the wild-type
conjugate. Substitution of the ABA group with BA reduced
the efficiency of recognition by N9 CTL by z50-fold (18).
As assessed by TCR photoaffinity labeling (see below), Kd
complexes with IASA-YIPSAEK(BA)I bound to the N9
TCR approximately seven times less efficiently than those
containing IASA-YIPSAEK(ABA)I (see Fig. 3 D). The ob-
servation that this weak agonist was significantly recognized
only by CD8a/b cells is in accordance with reports indi-
cating that CD8b broadens the range of antigen recogni-
tion by CD81 T cells (10, 11) and in addition provides a
quantitative correlation between antigen recognition and
TCR–ligand binding.
To find out why CD8a/b cells efficiently recognize
IASA-YIPSAEK(BA)I, we performed the previous experi-
ment (Fig. 1 C) in the presence of Fab9 fragments of the
anti-Kd a3 mAb SF1-1.1.1. This reagent has been shown
to impair participation of CD8 in TCR–ligand binding
while leaving CD8 mediated adhesion unaffected (19). As
shown in Fig. 2 A, this reagent abolished the efficient recog-
nition of IASA-YIPSAEK(BA)I. Similarly, CD8a/b cells
failed to recognize significantly this conjugate on L cells ex-
pressing mutant Kd D227K, though they well recognized
the wild type conjugate (Fig. 2 B). This Kd mutation has
been shown to dramatically impair CD8–MHC class I in-
teractions (5, 6, 19). The finding that CD8a/b cells under
conditions that prevent CD8 participation in TCR–ligand
binding failed, as CD8a/a cells, to significantly recognize
the weak agonist IASA-YIPSAEK(BA)I suggests that
CD8a/b more avidly strengthens TCR–ligand binding
than CD8a/a.
Table 1. Flow Cytometry on Cell Lines under Study
Cell line
Surface marker (mean fluorescence)
TCR
(H57-259)
CD8a
(53.6.72)
CD8b
(H35-17)
LFA1
(FD18.5)
Kd
(20-8-4S)
ICAM1
(YN1.1.7)
N9 CTL 259 272 155 316 ND ND
N9.12/2 187 4 3 308 ND ND
N9.1 a/a 143 753 11 229 ND ND
N9.1 a/b 194 792 95 187 ND ND
L-Kd wt ND ND ND ND 253 107
L-Kd D227K ND ND ND ND 765 145
Cells were stained with the antibodies indicated in parenthesis. The mean fluorescence intensities for a representative experiment are shown. The
histograms were monophasic for all cell lines/antibody combinations.
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The utilized system allowed to test this possibility, be-
cause it permits direct assessment of CD8 participation in
TCR-ligand binding by TCR photoaffinity labeling with sol-
uble covalent Kd–peptide derivative complexes (16, 17, 19).
TCR photoaffinity labeling with Kd-125IASA-YIPSAEK
(ABA)I on CD8a/b cells was z5 and 20 times more effi-
cient than on CD8a/a cells and CD82/2 cells, respectively
(Fig. 3, A and B). The background, e.g., nonspecific label-
ing, was 1–2%, as observed in the presence of the a-Kda1
mAb 20-8-4S, which blocks specific TCR–ligand binding
(16, 19). Because CD8a/a cells expressed more CD8a
than N9 CTL or CD8a/b cells expressed CD8a/b (Table 1),
these results demonstrate that heterodimeric CD8a/b in-
deed more avidly strengthens TCR–ligand binding than
homodimeric CD8a/a. This is in accordance with pre-
ceeding experiments, in which various CD8a and CD8a
plus CD8b transfectants of CD82/2 N9.1 cells or subclones
of CD8a/b WB1.2 were likewise tested (unpublished re-
sults).
Figure 2. The recognition of IASA-YIPSAEK(BA)I by CD8a/b cells
is abrogated by SF1-1.1.1 Fab9 and Kd mutation D227K. The IL-2 release
by CD8a/b cells was measured after incubation with L-Kd sensitized
with IASA-YIPSAEK(BA)I in the absence (s) or presence (d) of SF1-
1.1.1 Fab9 (A), as described for Fig. 1. Alternatively, L-Kd cells expressing
Kd D227K were used as presenting cells, which were sensitized either
with IASA-YIPSAEK(ABA)I (s) or IASA-YIPSAEK(BA)I (d) (B).
Figure 3. TCR photoaffinity labeling with soluble ligand Kd–peptide
derivative complexes. CD8a/b, CD8a/a or CD82/2 cells were incu-
bated with Kd-125IASA-YIPSAEK(ABA)I in absence (black bars) or presence
of SF1-1.1.1 Fab9 (20 mg/ml) (white bars) or 20-8-4S mAb (10 mg/ml)
(hatched bars), and TCR photoaffinity labeling was evaluated by SDS-
PAGE and autoradiography (A) and densitometry (B). Alternatively,
CD8a/b and CD82/2 cells, respectively, were tested likewise, either with
Kd-IASA-YIPSAEK(ABA)I (black bars) or mutant KdD227K-IASA-YIP-
SAEK(BA)I (white bars) (C). In both experiments, 100% refers to the
TCR labeling observed on CD8a/b cells with the wild type ligand. The
TCR binding of Kd-IASA-YIPSAEK(BA)I was assessed by its ability to
inhibit the TCR photoaffinity labeling by Kd-125IASA-YIPSAEK (ABA)I
on N9 CTL (D). Mean values and standard deviations were calculated
from at least three independent experiments.
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(Figs. 2 and 3). We thus conclude that CD8a/b cells more
efficiently recognize antigen than CD8a/a cells, because
CD8a/b more avidly strengthens TCR–ligand binding.
Although our results do not rule out that other factors may
play a role as well (i.e., that CD8a/b has superior signaling
capabilities or more efficiently mediates CD8-dependent
adhesion), they clearly demonstrate that CD8b significantly
increases CD8 participation in TCR–ligand binding, and
this predictably is important for antigen recognition, espe-
cially of weak agonists.
It remains to be explained why CD8a/b more effi-
ciently increases TCR–ligand binding than CD8a/a. It is
conceivable that either CD8a/b more avidly binds MHC
class I molecules or that it more efficiently “couples” with
TCR/CD3, thus defining an orientation of CD8 relative
to the TCR that favors coordinate ligand binding. Al-
though CD8a/a and CD8a/b both have been shown to
bind MHC class I molecules (5, 24), it is unknown whether
they do so with different affinities. In support of the second
possibility, we have previously observed that the dynamics
of TCR–ligand interactions on CTL clones are modulated
by CD8 in a time- and temperature-dependent manner
(16, 19). Moreover, several reports indicate that CD8 in-
teracts with TCR/CD3 complex (25, 26), which in view
of our present data may imply that CD8b plays an impor-
tant role in such interactions. Interestingly, CD8b has been
shown to significantly increase the association of CD8 with
the tyrosine kinase p56lck (15). In the CD4 system, p56lck is
known to be involved in coupling CD4 with TCR/CD3
(27). If the same were true for CD8, it would explain why
CD8a/b is a more efficient coreceptor than CD8a/a. The
system described here, by including kinetic experiments
and further genetic engineering of the hybridomas, should
now permit detailed analysis of the role of CD8b in T cell
function.
The efficient TCR photoaffinity labeling on CD8a/b cells
was reduced in the presence of SF1-1.1.1 Fab9 to the same
low levels as observed on CD82/2 cells (Fig. 3, A and B).
The TCR photoaffinity labeling on CD8a/a was also re-
duced in the presence of this reagent, but for unknown
reasons to a slightly lesser degree than on CD8a/b cells.
The lack of a significant inhibition of the TCR photoaffin-
ity labeling on CD82/2 cells in the presence of SF1-1.1.1
Fab9 showed that this reagent does not affect the TCR–
ligand interaction per se, but rather the CD8 participation
in TCR–ligand binding. Similarly, when TCR photoaffin-
ity labeling on CD8a/b cells was performed with soluble
Kd D227K-IASA-YIPSAEK(ABA)I, nearly five times weaker
labeling was observed than with the wild type ligand (Fig. 3
C). In contrast, on CD82/2 cells, both ligands exhibited es-
sentially the same weak TCR photoaffinity labeling, con-
firming our previous finding that this Kd mutation does not
significantly affect the actual TCR–ligand binding, but
rather its dependence on CD8 (Fig. 3 B and reference 19).
The peptide derivative variant IASA-YIPSAEK(BA)I, lack-
ing an orthogonal photoreactive group, can cross-link to
Kd, but not to TCR; therefore, the binding of Kd-IASA-
YIPSAEK(BA)I to N9 TCR was assessed by its ability to
inhibit the TCR photoaffinity labeling by Kd-IASA-YIP-
SAEK(ABA)I. As shown in Fig. 3 D, the TCR photoaffinity
labeling on N9 CTL was inhibited in a linear fashion in the
presence of graded amounts of Kd-125IASA-YIPSAEK(BA)I.
By extrapolation, 50% of inhibition was observed at z6.8-
fold molar excess of variant ligand.
Taken collectively, the results of the TCR photoaffinity
labeling experiments correlate well with those of the IL-2
release experiments. Most strikingly, SF1-1.1.1 Fab9 and Kd
mutation D227K inhibited the efficient recognition of the
conjugate variant IASA-YIPSAEK(BA)I by CD8a/b cells,
because they inhibited the TCR photoaffinity labeling
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